 Robert Wilson
Concepts (499)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cognition Disorders | 110 | 2019 | 1042 | 13.700 |
Why?
| | Aging | 84 | 2018 | 1265 | 11.110 |
Why?
| | Alzheimer Disease | 99 | 2019 | 1384 | 10.350 |
Why?
| | Cognition | 74 | 2019 | 883 | 8.520 |
Why?
| | Dementia | 26 | 2019 | 420 | 6.120 |
Why?
| | Aged, 80 and over | 182 | 2019 | 4342 | 6.030 |
Why?
| | Longitudinal Studies | 105 | 2019 | 1148 | 5.980 |
Why?
| | Aged | 215 | 2019 | 8523 | 5.570 |
Why?
| | Brain | 50 | 2019 | 1224 | 5.520 |
Why?
| | Neuropsychological Tests | 93 | 2019 | 1138 | 5.080 |
Why?
| | European Continental Ancestry Group | 43 | 2018 | 524 | 4.390 |
Why?
| | Male | 229 | 2019 | 14935 | 4.360 |
Why?
| | Female | 226 | 2019 | 15291 | 4.260 |
Why?
| | Memory | 23 | 2018 | 307 | 3.810 |
Why?
| | Humans | 246 | 2019 | 25732 | 3.620 |
Why?
| | Depression | 21 | 2016 | 422 | 3.550 |
Why?
| | African Americans | 33 | 2018 | 617 | 3.210 |
Why?
| | Personality | 7 | 2015 | 58 | 2.780 |
Why?
| | Disease Progression | 32 | 2019 | 735 | 2.680 |
Why?
| | DNA-Binding Proteins | 9 | 2019 | 225 | 2.620 |
Why?
| | Memory Disorders | 10 | 2018 | 156 | 2.510 |
Why?
| | Olfaction Disorders | 6 | 2016 | 29 | 2.470 |
Why?
| | Stress, Psychological | 9 | 2014 | 253 | 2.420 |
Why?
| | Cohort Studies | 52 | 2019 | 1548 | 2.350 |
Why?
| | Memory, Episodic | 7 | 2019 | 78 | 2.260 |
Why?
| | Risk Factors | 60 | 2018 | 2208 | 2.010 |
Why?
| | Lewy Bodies | 8 | 2019 | 140 | 1.910 |
Why?
| | Educational Status | 17 | 2019 | 233 | 1.910 |
Why?
| | Follow-Up Studies | 39 | 2019 | 1775 | 1.870 |
Why?
| | Apolipoproteins E | 17 | 2018 | 162 | 1.830 |
Why?
| | Interpersonal Relations | 8 | 2014 | 106 | 1.790 |
Why?
| | Mortality | 9 | 2016 | 63 | 1.740 |
Why?
| | Cerebral Infarction | 8 | 2015 | 143 | 1.700 |
Why?
| | Chicago | 36 | 2018 | 780 | 1.680 |
Why?
| | Motor Activity | 18 | 2015 | 368 | 1.660 |
Why?
| | Neurodegenerative Diseases | 3 | 2018 | 85 | 1.630 |
Why?
| | Geriatric Assessment | 24 | 2017 | 211 | 1.600 |
Why?
| | Apolipoprotein E4 | 18 | 2018 | 176 | 1.580 |
Why?
| | Hospitalization | 4 | 2019 | 262 | 1.540 |
Why?
| | Activities of Daily Living | 23 | 2013 | 396 | 1.510 |
Why?
| | African Continental Ancestry Group | 15 | 2018 | 163 | 1.500 |
Why?
| | Anxiety | 4 | 2013 | 128 | 1.460 |
Why?
| | Neurofibrillary Tangles | 10 | 2017 | 155 | 1.460 |
Why?
| | Parkinsonian Disorders | 9 | 2019 | 136 | 1.450 |
Why?
| | Learning | 2 | 2018 | 84 | 1.420 |
Why?
| | Neurotic Disorders | 6 | 2018 | 20 | 1.330 |
Why?
| | Incidence | 26 | 2018 | 692 | 1.260 |
Why?
| | Loneliness | 6 | 2018 | 41 | 1.260 |
Why?
| | Health Literacy | 4 | 2018 | 61 | 1.240 |
Why?
| | Proportional Hazards Models | 22 | 2017 | 322 | 1.230 |
Why?
| | Agnosia | 2 | 2016 | 10 | 1.180 |
Why?
| | Memory, Short-Term | 5 | 2019 | 73 | 1.180 |
Why?
| | Neurons | 4 | 2013 | 363 | 1.170 |
Why?
| | Perception | 3 | 2019 | 77 | 1.160 |
Why?
| | Autopsy | 12 | 2019 | 236 | 1.120 |
Why?
| | Middle Aged | 42 | 2018 | 9627 | 1.110 |
Why?
| | Genetic Predisposition to Disease | 12 | 2017 | 405 | 1.050 |
Why?
| | Hippocampus | 5 | 2019 | 233 | 1.040 |
Why?
| | Amyloid beta-Peptides | 5 | 2017 | 175 | 1.030 |
Why?
| | Hispanic Americans | 5 | 2015 | 168 | 1.020 |
Why?
| | Language | 3 | 2014 | 62 | 1.020 |
Why?
| | Research Design | 4 | 2014 | 183 | 1.000 |
Why?
| | Age Factors | 22 | 2018 | 794 | 0.990 |
Why?
| | Risk | 18 | 2018 | 205 | 0.980 |
Why?
| | Disabled Persons | 6 | 2013 | 80 | 0.960 |
Why?
| | Child Abuse | 2 | 2012 | 27 | 0.960 |
Why?
| | Chronic Disease | 5 | 2017 | 465 | 0.910 |
Why?
| | Anxiety Disorders | 3 | 2016 | 175 | 0.910 |
Why?
| | Cognitive Reserve | 1 | 2019 | 20 | 0.900 |
Why?
| | Nervous System Diseases | 3 | 2018 | 112 | 0.850 |
Why?
| | Psychiatric Status Rating Scales | 12 | 2016 | 378 | 0.830 |
Why?
| | Reading | 4 | 2016 | 35 | 0.820 |
Why?
| | Ambulatory Care | 1 | 2017 | 79 | 0.790 |
Why?
| | Brain Stem | 2 | 2016 | 27 | 0.790 |
Why?
| | United States | 24 | 2019 | 1991 | 0.780 |
Why?
| | Locus Coeruleus | 2 | 2013 | 25 | 0.770 |
Why?
| | Comorbidity | 14 | 2018 | 474 | 0.760 |
Why?
| | Urban Population | 4 | 2013 | 135 | 0.760 |
Why?
| | Depressive Disorder | 4 | 2019 | 209 | 0.760 |
Why?
| | Prospective Studies | 25 | 2019 | 1520 | 0.740 |
Why?
| | Brain Chemistry | 1 | 2016 | 49 | 0.730 |
Why?
| | Longevity | 2 | 2013 | 32 | 0.700 |
Why?
| | Motor Skills | 2 | 2013 | 47 | 0.700 |
Why?
| | Exercise | 6 | 2019 | 322 | 0.700 |
Why?
| | Plaque, Amyloid | 7 | 2017 | 129 | 0.700 |
Why?
| | Depressive Disorder, Major | 1 | 2016 | 100 | 0.680 |
Why?
| | Genotype | 17 | 2018 | 384 | 0.680 |
Why?
| | Music | 1 | 2014 | 16 | 0.670 |
Why?
| | Multilingualism | 1 | 2014 | 16 | 0.660 |
Why?
| | Quality of Life | 3 | 2015 | 508 | 0.650 |
Why?
| | Frail Elderly | 5 | 2014 | 41 | 0.650 |
Why?
| | Decision Making | 5 | 2018 | 175 | 0.650 |
Why?
| | Lewy Body Disease | 5 | 2018 | 81 | 0.650 |
Why?
| | Severity of Illness Index | 15 | 2019 | 1115 | 0.640 |
Why?
| | Mesencephalon | 1 | 2013 | 48 | 0.630 |
Why?
| | Alleles | 11 | 2018 | 182 | 0.610 |
Why?
| | Disability Evaluation | 12 | 2015 | 292 | 0.600 |
Why?
| | Independent Living | 6 | 2019 | 101 | 0.600 |
Why?
| | Membrane Transport Proteins | 3 | 2017 | 43 | 0.590 |
Why?
| | Personal Satisfaction | 1 | 2013 | 42 | 0.590 |
Why?
| | Awareness | 3 | 2018 | 41 | 0.590 |
Why?
| | Sex Factors | 12 | 2018 | 440 | 0.580 |
Why?
| | Mental Health | 2 | 2016 | 79 | 0.570 |
Why?
| | Psychomotor Performance | 7 | 2018 | 209 | 0.570 |
Why?
| | Cross-Sectional Studies | 14 | 2017 | 767 | 0.560 |
Why?
| | Emotions | 1 | 2012 | 86 | 0.550 |
Why?
| | Extraversion (Psychology) | 3 | 2013 | 12 | 0.550 |
Why?
| | Brain Diseases | 2 | 2013 | 59 | 0.530 |
Why?
| | Death | 2 | 2010 | 21 | 0.530 |
Why?
| | Mobility Limitation | 6 | 2015 | 75 | 0.530 |
Why?
| | Muscle Strength | 6 | 2009 | 115 | 0.520 |
Why?
| | Residence Characteristics | 9 | 2015 | 194 | 0.520 |
Why?
| | Knowledge | 1 | 2010 | 18 | 0.510 |
Why?
| | Telephone | 1 | 2010 | 31 | 0.510 |
Why?
| | Family Health | 1 | 2010 | 37 | 0.510 |
Why?
| | Time Factors | 14 | 2017 | 1680 | 0.500 |
Why?
| | Recognition (Psychology) | 3 | 2006 | 40 | 0.500 |
Why?
| | Diet | 4 | 2010 | 171 | 0.500 |
Why?
| | Psychological Tests | 4 | 2013 | 65 | 0.490 |
Why?
| | Linear Models | 12 | 2017 | 257 | 0.470 |
Why?
| | Psychometrics | 11 | 2012 | 242 | 0.470 |
Why?
| | Cerebral Amyloid Angiopathy | 3 | 2015 | 64 | 0.470 |
Why?
| | Clergy | 11 | 2013 | 68 | 0.460 |
Why?
| | Life | 2 | 2006 | 7 | 0.460 |
Why?
| | Mental Status Schedule | 9 | 2017 | 124 | 0.460 |
Why?
| | Diagnosis, Differential | 1 | 2011 | 442 | 0.460 |
Why?
| | Sclerosis | 3 | 2019 | 44 | 0.460 |
Why?
| | Blood Pressure | 4 | 2018 | 208 | 0.440 |
Why?
| | Models, Psychological | 5 | 2015 | 86 | 0.430 |
Why?
| | Language Tests | 2 | 2013 | 24 | 0.430 |
Why?
| | Antioxidants | 3 | 2005 | 70 | 0.430 |
Why?
| | Social Support | 4 | 2014 | 186 | 0.420 |
Why?
| | Social Class | 2 | 2005 | 54 | 0.420 |
Why?
| | Homes for the Aged | 1 | 2007 | 9 | 0.410 |
Why?
| | Outcome Assessment (Health Care) | 1 | 2010 | 278 | 0.410 |
Why?
| | Parkinson Disease | 7 | 2017 | 1001 | 0.410 |
Why?
| | Stroke | 3 | 2016 | 306 | 0.410 |
Why?
| | Logistic Models | 8 | 2017 | 452 | 0.410 |
Why?
| | Nursing Homes | 1 | 2007 | 32 | 0.400 |
Why?
| | Feeding Behavior | 2 | 2005 | 118 | 0.400 |
Why?
| | Community Health Planning | 3 | 2011 | 21 | 0.400 |
Why?
| | Dietary Fats | 2 | 2006 | 45 | 0.390 |
Why?
| | Risk Assessment | 10 | 2018 | 674 | 0.390 |
Why?
| | Vitamin E | 3 | 2005 | 50 | 0.390 |
Why?
| | Intelligence | 1 | 2006 | 28 | 0.390 |
Why?
| | Decision Support Techniques | 1 | 2006 | 50 | 0.380 |
Why?
| | Smell | 2 | 2016 | 15 | 0.380 |
Why?
| | TDP-43 Proteinopathies | 2 | 2017 | 30 | 0.380 |
Why?
| | Personality Disorders | 1 | 2006 | 21 | 0.380 |
Why?
| | Mental Recall | 5 | 2014 | 65 | 0.370 |
Why?
| | Risk-Taking | 1 | 2006 | 37 | 0.370 |
Why?
| | Fish Products | 1 | 2005 | 3 | 0.370 |
Why?
| | Delusions | 1 | 2005 | 13 | 0.370 |
Why?
| | Fishes | 1 | 2005 | 7 | 0.370 |
Why?
| | Social Behavior | 5 | 2011 | 101 | 0.360 |
Why?
| | Adult | 14 | 2015 | 8409 | 0.360 |
Why?
| | Factor Analysis, Statistical | 3 | 2015 | 68 | 0.350 |
Why?
| | Diet Surveys | 2 | 2006 | 24 | 0.350 |
Why?
| | Genetic Variation | 3 | 2017 | 106 | 0.340 |
Why?
| | Reproducibility of Results | 7 | 2012 | 751 | 0.340 |
Why?
| | Mood Disorders | 1 | 2005 | 32 | 0.340 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2016 | 181 | 0.340 |
Why?
| | Hallucinations | 1 | 2005 | 93 | 0.340 |
Why?
| | Interviews as Topic | 1 | 2005 | 128 | 0.330 |
Why?
| | Self Report | 3 | 2015 | 166 | 0.330 |
Why?
| | Nutrition Disorders | 1 | 2003 | 11 | 0.320 |
Why?
| | Life Change Events | 2 | 2014 | 40 | 0.320 |
Why?
| | Personality Inventory | 4 | 2009 | 82 | 0.320 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2006 | 156 | 0.320 |
Why?
| | Continental Population Groups | 3 | 2010 | 94 | 0.320 |
Why?
| | Health Status | 7 | 2012 | 235 | 0.310 |
Why?
| | Child | 4 | 2013 | 1335 | 0.310 |
Why?
| | Anger | 1 | 2003 | 29 | 0.310 |
Why?
| | Movement Disorders | 3 | 2010 | 123 | 0.310 |
Why?
| | Gait Disorders, Neurologic | 5 | 2009 | 123 | 0.310 |
Why?
| | Affect | 1 | 2003 | 68 | 0.300 |
Why?
| | Diabetes Complications | 3 | 2016 | 56 | 0.300 |
Why?
| | Social Adjustment | 3 | 2009 | 32 | 0.300 |
Why?
| | Polymorphism, Single Nucleotide | 5 | 2016 | 297 | 0.300 |
Why?
| | Catholicism | 5 | 2013 | 20 | 0.300 |
Why?
| | Vitamin A | 1 | 2002 | 7 | 0.290 |
Why?
| | Carotenoids | 1 | 2002 | 11 | 0.290 |
Why?
| | Leg | 3 | 2007 | 46 | 0.290 |
Why?
| | Models, Statistical | 5 | 2016 | 136 | 0.290 |
Why?
| | Self Stimulation | 1 | 2002 | 12 | 0.290 |
Why?
| | Substantia Nigra | 3 | 2019 | 132 | 0.280 |
Why?
| | Reaction Time | 2 | 2015 | 105 | 0.270 |
Why?
| | Statistics, Nonparametric | 4 | 2015 | 157 | 0.270 |
Why?
| | tau Proteins | 4 | 2017 | 129 | 0.260 |
Why?
| | Epidemiologic Studies | 3 | 2012 | 26 | 0.260 |
Why?
| | Prognosis | 4 | 2018 | 845 | 0.250 |
Why?
| | Magnetic Resonance Imaging | 6 | 2018 | 1056 | 0.250 |
Why?
| | Musculoskeletal Diseases | 2 | 2010 | 31 | 0.250 |
Why?
| | Synapses | 2 | 2012 | 43 | 0.250 |
Why?
| | Socioeconomic Factors | 5 | 2018 | 323 | 0.250 |
Why?
| | Muscle Rigidity | 3 | 2014 | 26 | 0.250 |
Why?
| | Prevalence | 4 | 2018 | 477 | 0.240 |
Why?
| | Cardiovascular Diseases | 2 | 2017 | 300 | 0.240 |
Why?
| | Prefrontal Cortex | 2 | 2019 | 131 | 0.240 |
Why?
| | Confidence Intervals | 7 | 2017 | 104 | 0.240 |
Why?
| | Smoking | 3 | 2012 | 167 | 0.230 |
Why?
| | Insulin-Like Growth Factor Binding Protein 5 | 1 | 2019 | 12 | 0.230 |
Why?
| | Social Environment | 2 | 2012 | 85 | 0.230 |
Why?
| | Antihypertensive Agents | 2 | 2018 | 62 | 0.230 |
Why?
| | TNF-Related Apoptosis-Inducing Ligand | 1 | 2018 | 8 | 0.230 |
Why?
| | Emergencies | 1 | 2019 | 27 | 0.230 |
Why?
| | Haplotypes | 2 | 2017 | 58 | 0.230 |
Why?
| | Primary Prevention | 1 | 2019 | 33 | 0.220 |
Why?
| | Parents | 2 | 2012 | 89 | 0.220 |
Why?
| | Visual Perception | 2 | 2011 | 64 | 0.220 |
Why?
| | Economics | 1 | 2018 | 24 | 0.220 |
Why?
| | Genome-Wide Association Study | 3 | 2016 | 238 | 0.220 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2018 | 53 | 0.210 |
Why?
| | Odds Ratio | 6 | 2017 | 279 | 0.210 |
Why?
| | Predictive Value of Tests | 5 | 2018 | 552 | 0.210 |
Why?
| | Gait | 5 | 2014 | 319 | 0.210 |
Why?
| | Health Behavior | 2 | 2010 | 151 | 0.210 |
Why?
| | Osteoporosis | 1 | 2018 | 66 | 0.210 |
Why?
| | Neoplasms | 2 | 2018 | 222 | 0.210 |
Why?
| | Urinary Incontinence | 1 | 2017 | 24 | 0.210 |
Why?
| | Pain | 2 | 2010 | 273 | 0.200 |
Why?
| | Apolipoprotein E3 | 1 | 2017 | 8 | 0.200 |
Why?
| | Education | 3 | 2006 | 38 | 0.200 |
Why?
| | Homozygote | 1 | 2017 | 25 | 0.200 |
Why?
| | Brain Infarction | 3 | 2016 | 66 | 0.200 |
Why?
| | Delivery of Health Care | 1 | 2018 | 69 | 0.200 |
Why?
| | Polymorphism, Genetic | 1 | 2017 | 90 | 0.200 |
Why?
| | Gene Expression | 1 | 2018 | 253 | 0.190 |
Why?
| | Biostatistics | 1 | 2016 | 6 | 0.190 |
Why?
| | Prejudice | 2 | 2008 | 38 | 0.190 |
Why?
| | Employment | 1 | 2016 | 30 | 0.190 |
Why?
| | Statistics as Topic | 4 | 2017 | 125 | 0.180 |
Why?
| | Life Style | 4 | 2014 | 175 | 0.180 |
Why?
| | Age Distribution | 3 | 2011 | 114 | 0.180 |
Why?
| | Attention | 3 | 2005 | 140 | 0.180 |
Why?
| | Regression Analysis | 6 | 2018 | 304 | 0.180 |
Why?
| | Rejection (Psychology) | 1 | 2014 | 6 | 0.180 |
Why?
| | Dentin | 2 | 2005 | 2 | 0.170 |
Why?
| | Age of Onset | 3 | 2013 | 106 | 0.170 |
Why?
| | Neurologic Examination | 2 | 2013 | 149 | 0.170 |
Why?
| | Empathy | 1 | 2014 | 37 | 0.170 |
Why?
| | Dancing | 1 | 2014 | 6 | 0.170 |
Why?
| | Harm Reduction | 1 | 2014 | 6 | 0.170 |
Why?
| | Cerebral Cortex | 1 | 2016 | 164 | 0.160 |
Why?
| | Raphe Nuclei | 1 | 2013 | 9 | 0.160 |
Why?
| | Ventral Tegmental Area | 1 | 2013 | 11 | 0.160 |
Why?
| | Religion | 1 | 2013 | 24 | 0.160 |
Why?
| | Locomotion | 1 | 2014 | 37 | 0.160 |
Why?
| | Cell Count | 1 | 2013 | 116 | 0.160 |
Why?
| | Financial Management | 1 | 2013 | 17 | 0.160 |
Why?
| | Cholinergic Antagonists | 1 | 2013 | 14 | 0.160 |
Why?
| | Social Isolation | 2 | 2018 | 19 | 0.150 |
Why?
| | Illinois | 4 | 2017 | 216 | 0.150 |
Why?
| | Survival Analysis | 2 | 2005 | 360 | 0.150 |
Why?
| | Hypokinesia | 2 | 2014 | 22 | 0.150 |
Why?
| | Nerve Degeneration | 1 | 2013 | 47 | 0.150 |
Why?
| | Health Status Disparities | 1 | 2013 | 48 | 0.150 |
Why?
| | Religion and Psychology | 2 | 2010 | 25 | 0.150 |
Why?
| | Anomie | 1 | 2012 | 4 | 0.140 |
Why?
| | Insulin Receptor Substrate Proteins | 1 | 2012 | 14 | 0.140 |
Why?
| | Young Adult | 3 | 2013 | 1802 | 0.140 |
Why?
| | Patient Dropouts | 1 | 2012 | 30 | 0.140 |
Why?
| | Hydrocortisone | 1 | 2012 | 45 | 0.140 |
Why?
| | Health Promotion | 1 | 2014 | 159 | 0.140 |
Why?
| | Personality Assessment | 3 | 2006 | 40 | 0.140 |
Why?
| | Association | 1 | 2011 | 8 | 0.140 |
Why?
| | Insulin Resistance | 1 | 2012 | 57 | 0.140 |
Why?
| | Choice Behavior | 1 | 2012 | 57 | 0.140 |
Why?
| | Inhibition (Psychology) | 1 | 2011 | 21 | 0.140 |
Why?
| | Tremor | 2 | 2014 | 93 | 0.140 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2012 | 60 | 0.140 |
Why?
| | Post-Synaptic Density | 1 | 2011 | 2 | 0.140 |
Why?
| | Corticosterone | 1 | 2011 | 3 | 0.140 |
Why?
| | Population Surveillance | 3 | 2015 | 118 | 0.130 |
Why?
| | Receptors, Complement 3b | 1 | 2011 | 15 | 0.130 |
Why?
| | Microfilament Proteins | 1 | 2011 | 26 | 0.130 |
Why?
| | Endophenotypes | 1 | 2011 | 13 | 0.130 |
Why?
| | Wechsler Scales | 2 | 2010 | 15 | 0.130 |
Why?
| | Nerve Tissue Proteins | 1 | 2012 | 149 | 0.130 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2011 | 35 | 0.130 |
Why?
| | Child, Preschool | 1 | 2013 | 725 | 0.130 |
Why?
| | Motor Skills Disorders | 1 | 2010 | 21 | 0.130 |
Why?
| | Genetic Association Studies | 3 | 2017 | 70 | 0.130 |
Why?
| | CA3 Region, Hippocampal | 1 | 2010 | 6 | 0.130 |
Why?
| | Cost-Benefit Analysis | 1 | 2011 | 122 | 0.130 |
Why?
| | Diet, Mediterranean | 1 | 2010 | 28 | 0.130 |
Why?
| | Microtubule-Associated Proteins | 1 | 2010 | 21 | 0.130 |
Why?
| | Confounding Factors (Epidemiology) | 2 | 2012 | 21 | 0.130 |
Why?
| | Retention (Psychology) | 2 | 2006 | 10 | 0.120 |
Why?
| | HIV Infections | 1 | 2017 | 797 | 0.120 |
Why?
| | Membrane Proteins | 1 | 2011 | 182 | 0.120 |
Why?
| | Self Care | 1 | 2010 | 102 | 0.120 |
Why?
| | Life Expectancy | 1 | 2009 | 19 | 0.120 |
Why?
| | Somatosensory Disorders | 1 | 2009 | 10 | 0.120 |
Why?
| | Hostility | 1 | 2009 | 19 | 0.120 |
Why?
| | Immunohistochemistry | 4 | 2017 | 464 | 0.120 |
Why?
| | Sensory Thresholds | 1 | 2009 | 25 | 0.120 |
Why?
| | Adolescent | 2 | 2013 | 2305 | 0.120 |
Why?
| | Vibration | 1 | 2009 | 30 | 0.110 |
Why?
| | Amyloid | 2 | 2010 | 39 | 0.110 |
Why?
| | Caspase 3 | 1 | 2008 | 32 | 0.110 |
Why?
| | Differential Threshold | 1 | 2008 | 3 | 0.110 |
Why?
| | Fatty Acids, Omega-3 | 2 | 2005 | 25 | 0.110 |
Why?
| | Retrospective Studies | 2 | 2013 | 2588 | 0.110 |
Why?
| | Acid Etching, Dental | 2 | 2005 | 3 | 0.110 |
Why?
| | Hemoglobins | 1 | 2008 | 77 | 0.110 |
Why?
| | Survival Rate | 1 | 2009 | 394 | 0.110 |
Why?
| | Data Collection | 2 | 2005 | 121 | 0.100 |
Why?
| | Hand Strength | 1 | 2007 | 46 | 0.100 |
Why?
| | Discrimination (Psychology) | 1 | 2007 | 26 | 0.100 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2008 | 92 | 0.100 |
Why?
| | Personal Space | 1 | 2007 | 7 | 0.100 |
Why?
| | Perceptual Disorders | 1 | 2006 | 6 | 0.100 |
Why?
| | Latin America | 1 | 2006 | 6 | 0.100 |
Why?
| | Likelihood Functions | 2 | 2017 | 32 | 0.100 |
Why?
| | Spouses | 1 | 2006 | 25 | 0.100 |
Why?
| | Trans Fatty Acids | 1 | 2006 | 7 | 0.100 |
Why?
| | Copper | 1 | 2006 | 12 | 0.100 |
Why?
| | Space Perception | 1 | 2006 | 33 | 0.100 |
Why?
| | Dyskinesias | 1 | 2006 | 26 | 0.100 |
Why?
| | Disease Susceptibility | 1 | 2006 | 67 | 0.100 |
Why?
| | Ambulatory Care Facilities | 1 | 2006 | 32 | 0.100 |
Why?
| | Fatty Acids | 1 | 2006 | 44 | 0.100 |
Why?
| | Medicare | 2 | 2019 | 72 | 0.100 |
Why?
| | Psychology | 1 | 2006 | 15 | 0.090 |
Why?
| | Fear | 1 | 2006 | 46 | 0.090 |
Why?
| | Data Interpretation, Statistical | 3 | 2016 | 94 | 0.090 |
Why?
| | Urban Health | 1 | 2006 | 28 | 0.090 |
Why?
| | Population Groups | 1 | 2005 | 5 | 0.090 |
Why?
| | Parent-Child Relations | 1 | 2006 | 34 | 0.090 |
Why?
| | Patient Readmission | 1 | 2007 | 90 | 0.090 |
Why?
| | Verbal Learning | 2 | 2004 | 38 | 0.090 |
Why?
| | Parkinson Disease, Secondary | 1 | 2005 | 28 | 0.090 |
Why?
| | Parenting | 1 | 2006 | 54 | 0.090 |
Why?
| | Molar, Third | 1 | 2005 | 1 | 0.090 |
Why?
| | Dentin-Bonding Agents | 1 | 2005 | 1 | 0.090 |
Why?
| | Dental Etching | 1 | 2005 | 1 | 0.090 |
Why?
| | Eating | 1 | 2005 | 53 | 0.090 |
Why?
| | Tocopherols | 1 | 2005 | 6 | 0.090 |
Why?
| | DNA | 1 | 2005 | 140 | 0.090 |
Why?
| | Family Characteristics | 1 | 2005 | 17 | 0.090 |
Why?
| | Water | 1 | 2005 | 36 | 0.090 |
Why?
| | Energy Intake | 1 | 2005 | 84 | 0.090 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2005 | 33 | 0.090 |
Why?
| | Tooth Demineralization | 1 | 2004 | 2 | 0.090 |
Why?
| | Sex Distribution | 3 | 2011 | 81 | 0.090 |
Why?
| | Postural Balance | 3 | 2014 | 103 | 0.080 |
Why?
| | Heterozygote | 2 | 2015 | 85 | 0.080 |
Why?
| | Sensitivity and Specificity | 3 | 2010 | 575 | 0.080 |
Why?
| | Markov Chains | 2 | 2015 | 31 | 0.080 |
Why?
| | Practice Guidelines as Topic | 1 | 2006 | 334 | 0.080 |
Why?
| | Seafood | 1 | 2003 | 17 | 0.080 |
Why?
| | Brief Psychiatric Rating Scale | 2 | 2015 | 9 | 0.080 |
Why?
| | Brain Mapping | 3 | 2012 | 178 | 0.080 |
Why?
| | Sleep | 1 | 2006 | 277 | 0.080 |
Why?
| | Health Surveys | 2 | 2013 | 95 | 0.070 |
Why?
| | Frontal Lobe | 1 | 2002 | 79 | 0.070 |
Why?
| | Interview, Psychological | 2 | 2014 | 45 | 0.060 |
Why?
| | Cerebrovascular Disorders | 2 | 2013 | 78 | 0.060 |
Why?
| | Intelligence Tests | 2 | 2014 | 15 | 0.060 |
Why?
| | Animals | 2 | 2011 | 4797 | 0.060 |
Why?
| | Body Mass Index | 2 | 2016 | 364 | 0.060 |
Why?
| | Nutrition Assessment | 3 | 2005 | 54 | 0.060 |
Why?
| | Blotting, Western | 2 | 2011 | 227 | 0.060 |
Why?
| | HSP27 Heat-Shock Proteins | 1 | 2019 | 12 | 0.060 |
Why?
| | Proteomics | 1 | 2019 | 38 | 0.060 |
Why?
| | Muscle Strength Dynamometer | 2 | 2009 | 16 | 0.060 |
Why?
| | Religious Personnel | 1 | 2018 | 11 | 0.050 |
Why?
| | Epidemiologic Research Design | 2 | 2010 | 16 | 0.050 |
Why?
| | Dementia, Vascular | 1 | 2018 | 39 | 0.050 |
Why?
| | Academic Medical Centers | 1 | 2018 | 133 | 0.050 |
Why?
| | Genetic Linkage | 1 | 2017 | 43 | 0.050 |
Why?
| | Diagnosis | 1 | 2017 | 24 | 0.050 |
Why?
| | Genotyping Techniques | 1 | 2017 | 12 | 0.050 |
Why?
| | Tuberous Sclerosis | 1 | 2017 | 13 | 0.050 |
Why?
| | Double-Blind Method | 1 | 2018 | 502 | 0.050 |
Why?
| | White Matter | 1 | 2018 | 93 | 0.050 |
Why?
| | Arteriolosclerosis | 1 | 2016 | 33 | 0.050 |
Why?
| | Anisotropy | 1 | 2016 | 49 | 0.050 |
Why?
| | Diffusion Tensor Imaging | 1 | 2016 | 57 | 0.050 |
Why?
| | Hypoglycemic Agents | 1 | 2016 | 64 | 0.050 |
Why?
| | Demography | 1 | 2016 | 72 | 0.050 |
Why?
| | Inflammation | 1 | 2018 | 285 | 0.040 |
Why?
| | Pattern Recognition, Visual | 2 | 2005 | 35 | 0.040 |
Why?
| | Hardness | 2 | 2005 | 6 | 0.040 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2016 | 221 | 0.040 |
Why?
| | Computer Simulation | 1 | 2016 | 216 | 0.040 |
Why?
| | Elasticity | 2 | 2005 | 55 | 0.040 |
Why?
| | Sex Characteristics | 1 | 2015 | 88 | 0.040 |
Why?
| | Surface Properties | 2 | 2005 | 127 | 0.040 |
Why?
| | Self Efficacy | 1 | 2014 | 54 | 0.040 |
Why?
| | Materials Testing | 2 | 2005 | 132 | 0.040 |
Why?
| | Medicare Part D | 1 | 2013 | 7 | 0.040 |
Why?
| | ROC Curve | 1 | 2014 | 118 | 0.040 |
Why?
| | Reference Values | 2 | 2004 | 244 | 0.040 |
Why?
| | Dietary Supplements | 2 | 2005 | 62 | 0.040 |
Why?
| | Databases, Factual | 1 | 2014 | 264 | 0.040 |
Why?
| | Executive Function | 1 | 2013 | 83 | 0.040 |
Why?
| | Neocortex | 1 | 2012 | 30 | 0.040 |
Why?
| | Drug Administration Schedule | 1 | 2013 | 250 | 0.040 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2012 | 16 | 0.040 |
Why?
| | Protein Array Analysis | 1 | 2012 | 12 | 0.040 |
Why?
| | Phosphoserine | 1 | 2012 | 5 | 0.040 |
Why?
| | Cerebellar Cortex | 1 | 2012 | 6 | 0.040 |
Why?
| | Multilevel Analysis | 1 | 2012 | 7 | 0.040 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2012 | 32 | 0.040 |
Why?
| | Aniline Compounds | 1 | 2012 | 31 | 0.040 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2012 | 32 | 0.040 |
Why?
| | Income | 1 | 2012 | 53 | 0.040 |
Why?
| | Models, Genetic | 1 | 2012 | 36 | 0.040 |
Why?
| | Protein Processing, Post-Translational | 1 | 2012 | 41 | 0.040 |
Why?
| | Thiazoles | 1 | 2012 | 36 | 0.040 |
Why?
| | Drug Resistance | 1 | 2012 | 63 | 0.040 |
Why?
| | Cyclic Nucleotide Phosphodiesterases, Type 7 | 1 | 2011 | 4 | 0.040 |
Why?
| | Glucose | 1 | 2012 | 57 | 0.040 |
Why?
| | Causality | 1 | 2011 | 50 | 0.030 |
Why?
| | Temporal Lobe | 1 | 2012 | 96 | 0.030 |
Why?
| | Positron-Emission Tomography | 1 | 2012 | 80 | 0.030 |
Why?
| | Mitochondrial Proteins | 1 | 2011 | 39 | 0.030 |
Why?
| | Phosphorylation | 1 | 2012 | 190 | 0.030 |
Why?
| | Niacinamide | 1 | 2011 | 5 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 2012 | 291 | 0.030 |
Why?
| | Insulin | 1 | 2012 | 90 | 0.030 |
Why?
| | Trail Making Test | 1 | 2010 | 3 | 0.030 |
Why?
| | Wine | 1 | 2010 | 7 | 0.030 |
Why?
| | Nutrition Policy | 1 | 2010 | 15 | 0.030 |
Why?
| | Adaptation, Psychological | 1 | 2012 | 154 | 0.030 |
Why?
| | Dendritic Spines | 1 | 2010 | 11 | 0.030 |
Why?
| | Dendrites | 1 | 2010 | 14 | 0.030 |
Why?
| | Piperazines | 1 | 2011 | 83 | 0.030 |
Why?
| | Retirement | 1 | 2009 | 11 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2011 | 361 | 0.030 |
Why?
| | Nerve Fibers, Myelinated | 1 | 2010 | 41 | 0.030 |
Why?
| | Internet | 1 | 2011 | 83 | 0.030 |
Why?
| | Mechanoreceptors | 1 | 2009 | 8 | 0.030 |
Why?
| | Proprioception | 1 | 2009 | 21 | 0.030 |
Why?
| | Mice, Inbred C57BL | 1 | 2011 | 442 | 0.030 |
Why?
| | Synaptosomes | 1 | 2008 | 4 | 0.030 |
Why?
| | Tissue Extracts | 1 | 2008 | 15 | 0.030 |
Why?
| | Ergometry | 1 | 2008 | 3 | 0.030 |
Why?
| | Protein Transport | 1 | 2008 | 41 | 0.030 |
Why?
| | Patient Compliance | 1 | 2010 | 199 | 0.030 |
Why?
| | Signal Transduction | 1 | 2012 | 517 | 0.030 |
Why?
| | Cytosol | 1 | 2008 | 61 | 0.030 |
Why?
| | Cell Nucleus | 1 | 2008 | 88 | 0.030 |
Why?
| | Joints | 1 | 2009 | 99 | 0.030 |
Why?
| | Enzyme Activation | 1 | 2008 | 144 | 0.030 |
Why?
| | Cause of Death | 1 | 2008 | 60 | 0.030 |
Why?
| | Algorithms | 1 | 2011 | 380 | 0.030 |
Why?
| | Aspirin | 1 | 2008 | 65 | 0.030 |
Why?
| | Observation | 1 | 2007 | 16 | 0.030 |
Why?
| | Visual Acuity | 1 | 2007 | 44 | 0.020 |
Why?
| | Psychotropic Drugs | 1 | 2007 | 30 | 0.020 |
Why?
| | Range of Motion, Articular | 1 | 2010 | 605 | 0.020 |
Why?
| | Forecasting | 1 | 2006 | 117 | 0.020 |
Why?
| | Mice | 1 | 2011 | 1618 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 2009 | 325 | 0.020 |
Why?
| | Verbal Behavior | 1 | 2005 | 22 | 0.020 |
Why?
| | Photic Stimulation | 1 | 2005 | 47 | 0.020 |
Why?
| | Cross-Cultural Comparison | 1 | 2005 | 39 | 0.020 |
Why?
| | Cultural Diversity | 1 | 2005 | 26 | 0.020 |
Why?
| | Community Mental Health Centers | 1 | 2005 | 5 | 0.020 |
Why?
| | Linkage Disequilibrium | 1 | 2005 | 40 | 0.020 |
Why?
| | Tissue Adhesions | 1 | 2005 | 10 | 0.020 |
Why?
| | Cementation | 1 | 2005 | 29 | 0.020 |
Why?
| | gamma-Tocopherol | 1 | 2005 | 10 | 0.020 |
Why?
| | alpha-Tocopherol | 1 | 2005 | 11 | 0.020 |
Why?
| | Gene Frequency | 1 | 2005 | 82 | 0.020 |
Why?
| | Logic | 1 | 2004 | 3 | 0.020 |
Why?
| | Practice (Psychology) | 1 | 2004 | 15 | 0.020 |
Why?
| | Dentin Permeability | 1 | 2004 | 1 | 0.020 |
Why?
| | Phosphoric Acids | 1 | 2004 | 1 | 0.020 |
Why?
| | Resin Cements | 1 | 2004 | 1 | 0.020 |
Why?
| | Phase Transition | 1 | 2004 | 2 | 0.020 |
Why?
| | Microscopy, Atomic Force | 1 | 2004 | 10 | 0.020 |
Why?
| | Desiccation | 1 | 2004 | 3 | 0.020 |
Why?
| | Comprehension | 1 | 2004 | 27 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2005 | 253 | 0.020 |
Why?
| | Cues | 1 | 2004 | 75 | 0.020 |
Why?
| | Sick Role | 1 | 2004 | 15 | 0.020 |
Why?
| | Health Status Indicators | 1 | 2005 | 83 | 0.020 |
Why?
| | Heart Failure | 1 | 2007 | 177 | 0.020 |
Why?
| | Speech Perception | 1 | 2004 | 51 | 0.020 |
Why?
| | Probability | 1 | 2004 | 94 | 0.020 |
Why?
| | Sampling Studies | 1 | 2003 | 32 | 0.020 |
Why?
| | Eicosapentaenoic Acid | 1 | 2003 | 9 | 0.020 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2003 | 13 | 0.020 |
Why?
| | Docosahexaenoic Acids | 1 | 2003 | 14 | 0.020 |
Why?
| | Walking | 1 | 2005 | 195 | 0.020 |
Why?
| | beta Carotene | 1 | 2002 | 16 | 0.020 |
Why?
| | Cluster Analysis | 1 | 2002 | 56 | 0.020 |
Why?
| | Ascorbic Acid | 1 | 2002 | 38 | 0.020 |
Why?
| | Hypotension | 1 | 2002 | 30 | 0.020 |
Why?
| | Dominance, Cerebral | 1 | 2002 | 24 | 0.020 |
Why?
| | Semantics | 1 | 2002 | 24 | 0.020 |
Why?
| | Arousal | 1 | 2002 | 62 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2002 | 121 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2002 | 355 | 0.020 |
Why?
| | Hypertension | 1 | 2002 | 212 | 0.020 |
Why?
|
|
Wilson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|